Towards a global initiative for fibrosis treatment (GIFT)

Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease characterised by increased scarring of lung tissue. Despite the recent introduction of novel drugs that slow disease progression, IPF remains a deadly disease, and the benefits of these new drugs differ markedly between patients. Huma...

Full description

Bibliographic Details
Main Authors: Maria Molina-Molina, Alvar Agusti, Bruno Crestani, David A. Schwartz, Melanie Königshoff, Rachel C. Chambers, Toby M. Maher, Rosa Faner, Ana Lucia Mora, Mauricio Rojas, Katerina M. Antoniou, Jacobo Sellares
Format: Article
Language:English
Published: European Respiratory Society 2017-12-01
Series:ERJ Open Research
Online Access:http://openres.ersjournals.com/content/3/4/00106-2017.full